Pharmaceutical Technology Europe-06-01-2011

Ingredients
Pharmaceutical Technology Europe

June 03, 2011

Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.

Pharmaceutical Technology Europe
Industry Insider

June 01, 2011

The greatest challenge faced by the EMA is the continuing expansion of the EU.

Pharmaceutical Technology Europe

BASF's Jan Bebber explains why immediate-release formulations boost drug efficacy and aid patient compliance.

Pharmaceutical Technology Europe
Special Feature

June 01, 2011

The rising popularity of fast dissolving, immediate-release dosage forms can be attributed to their convenience and ease of administration.

Pharmaceutical Technology Europe

It was a mixed crowd hosted by Dusseldorf in the middle of May.

News
Pharmaceutical Technology Europe

June 01, 2011

Microdosing for better medicines

Special Feature
Pharmaceutical Technology Europe

June 01, 2011

When it comes to immediate-release tablet formulations, the choice of disintegrant can have a significant effect on the rate and extent of drug dissolution.

Pharmaceutical Technology Europe
Disposables Advisor

June 01, 2011

Regions around the world are starting to follow the US trend in disposables and are working to solve common challenges.

Regulation
Pharmaceutical Technology Europe

June 01, 2011

In January 2011, a new version of Annex 11 was released by the European Commission along with a revision of Chapter 4 of its GMP on documentation to reflect the actualities of electronic record keeping, all of which come into full effect in June 2011.

Peer-Reviewed Research
Pharmaceutical Technology Europe

June 01, 2011

The authors compare three systems of single-screw extrusion using binary formulations for their suitability for producing pellets of various formulations and under various spheronization conditions.

Regulation
Pharmaceutical Technology Europe

June 01, 2011

In January 2011, the European Medicines Agency (EMA) announced the new revision of EudraLex Volume 4 (GMP) - Annex 11 'Computerised Systems', and the consequential amendment of EudraLex Volume 4 - Chapter 4 ?Documentation?.